5. Summary of studies: proportion of treated participants with microbiological confirmation.
Study | Country | Design | Setting | Smear (n/N) | Xpert (n/N) | RR (95% CI) |
Agizew 2019a | Botswana | stepped‐wedge | public HIV clinics | 18/57 | 102/199 | 1.62 (1.08 to 2.44) |
Calligaro 2015 | South Africa | RCT | intensive care units | 7/16 | 20/24 | 1.90 (1.06 to 3.41) |
Churchyard 2015 | South Africa | cluster‐RCT | primary health clinics | 189/291 | 196/250 | 1.20 (0.98 to 1.47) |
Cox 2014 | South Africa | cluster‐RCT | primary health clinic | 131/229 | 226/277 | 1.41 (1.13 to 1.77) |
Mupfumi 2014 | Zimbabwe | RCT | specialized hospital | 14/45 | 20/43 | 1.50 (0.87 to 2.57) |
Theron 2014a | multiple | RCT | primary health clinics | 120/317 | 190/320 | 1.57 (1.33 to 1.86) |
CI: confidence interval RCT: randomized controlled trial RR: risk ratio
All estimates use unadjusted, apart from Churchyard 2015, who reported imbalance due to a small number of large clusters.